Finerenone Gets Expanded FDA Approval in Heart Failure

(MedPage Today) -- The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
The nonsteroidal mineralocorticoid receptor antagonist (MRA) is the first of its class to win approval for treating...